Brief: Curis Announces Eleven Active Clinical Sites In TakeAim CLL Study
26/06/2026 14:56
BRIEF-Curis Announces Eleven Active Clinical Sites In TakeAim CLL Study June 26 (Reuters) - Curis Inc CRIS.O:
CURIS ANNOUNCES ELEVEN ACTIVE CLINICAL SITES IN TAKEAIM CLL STUDY, REAFFIRMS PATIENT DOSING GUIDANCE, AND REPORTS STOCKHOLDER APPROVAL OF REVERSE STOCK SPLIT
CURIS - REVERSE STOCK SPLIT APPROVED AT RATIO OF 1-FOR-5 TO 1-FOR-25
Source text: ID:nPn6jBdd1a
Further company coverage: CRIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Curis
See all newsBrief: Curis Announces Eleven Active Clinical Sites In TakeAim CLL Study
Curis Q1 operating loss widens as expenses rise
Curis Inc Q4 revenue misses estimates
Advisory: Alert incorrectly tagged to Curis Inc withdrawn
Brief: Curis Announces Closing Of Private Placement Totaling Up To $80.8 Million In Gross Proceeds